Informing the debate: hypomethylating agents/venetoclax or intensive chemotherapy to treat acute myeloid leukemias
For several decades, patients confronted with one of the most deadly cancers in humans, acute myeloid leukemias (AMLs), had also to face intense toxic treatments requiring weeks or months of hospit...
Authors
- Yogen Saunthararajah (ORCID: https://orcid.org/0000-0002-9757-1031)
- Michael Daunov (ORCID: https://orcid.org/0000-0002-3641-6265)
Institutions
- Cleveland Clinic (US)
- University Hospitals of Cleveland (US)
- Cancer Institute (WIA) (IN)
- Case Western Reserve University (US)
Publication Details
- Journal
- Leukemia & lymphoma/Leukemia and lymphoma
- Published
- 2026-07-25
- DOI
- https://doi.org/10.1080/10428194.2026.2707894
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Heart, Lung, and Blood Institute